Block of bcr-abl expression and induction of apoptosis by cisplatinum in a human chronic myeloid leukaemia cell line
- 1 October 1996
- journal article
- Published by Springer Nature in Apoptosis
- Vol. 1 (2) , 161-166
- https://doi.org/10.1007/bf01321023
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Bad, a heterodimeric partner for Bcl-xL and Bcl-2, displaces bax and promotes cell deathCell, 1995
- Cloning and functional analysis of BAG-1: A novel Bcl-2-binding protein with anti-cell death activityCell, 1995
- Antisense inhibition of P210bcr‐ablin chronic myeloid leukemiaThe International Journal of Cell Cloning, 1993
- Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programed cell deathCell, 1993
- p53 is required for radiation-induced apoptosis in mouse thymocytesNature, 1993
- Inhibition of P210 Expression in Chronic Myeloid Leukaemia: Oligonucleotides and/or Transduced Antisense SequencesLeukemia & Lymphoma, 1993
- ABL proteins in Philadelphia‐positive acute leukaemias and chronic myelogenous leukaemia blast crisesBritish Journal of Haematology, 1990
- Tyrosine Kinase Activity and Transformation Potency of bcr-abl Oncogene ProductsScience, 1990
- The Chronic Myelogenous Leukemia-Specific P210 Protein Is the Product of the bcr / abl Hybrid GeneScience, 1986
- Isolation of biologically active ribonucleic acid from sources enriched in ribonucleaseBiochemistry, 1979